BMY
46
-4
NVDA
57
-4
INTU
69
-5
MAS
51
-7
PRU
50
-7
DD
38
-4
PX
43
-6
HOG
33
-3
MHK
42
-7
STI
16
-5
QRVO
57
-4
CL
43
-8
HST
22
-5
SLG
50
-3
SCHW
67
6
GPC
31
-6
MET
58
-3
SPG
40
-5
HBAN
59
-8
AMGN
28
-3
BMY
46
-4
NVDA
57
-4
INTU
69
-5
MAS
51
-7
PRU
50
-7
DD
38
-4
PX
43
-6
HOG
33
-3
MHK
42
-7
STI
16
-5
QRVO
57
-4
CL
43
-8
HST
22
-5
SLG
50
-3
SCHW
67
6
GPC
31
-6
MET
58
-3
SPG
40
-5
HBAN
59
-8
AMGN
28
-3
Financhill
Back

The Bancorp Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
63

TBBK
The Bancorp

Last Price:
$50.18
Seasonality Move:
-2.95%
Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
$18.30
Seasonality Move:
-0.62%
Buy
63
The Bancorp (TBBK) is a Buy

Is The Bancorp a Buy, Sell or Hold?

  • The current The Bancorp [TBBK] share price is $50.60. The Score for TBBK is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • TBBK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $18.83. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBBK Stock Price Chart

What is The Bancorp's stock price today?

  • The The Bancorp share price today is $50.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBBK is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $18.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

TBBK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 45.74 Sell
Chaikin Money Flow: 278676 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.79 - 53.95) Sell
Bollinger Bands (100): (48.15 - 57.75) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 51.68 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.04 - 19.02) Buy
Bollinger Bands (100): (18.02 - 27.22) Sell

TBBK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52 Sell
20-day SMA: 52.01 Sell
50-day SMA: 49.8 Buy
200-day SMA: 53.21 Sell
8-day EMA: 51.9 Sell
20-day EMA: 51.8 Sell
50-day EMA: 51.57 Sell
200-day EMA: 50.82 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.15 Sell
20-day SMA: 18.27 Buy
50-day SMA: 18.45 Buy
200-day SMA: 27.26 Sell
8-day EMA: 19 Sell
20-day EMA: 18.61 Buy
50-day EMA: 19.47 Sell
200-day EMA: 27.34 Sell

The Bancorp Earnings Growth & TBBK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.21 per share, an increase this year of $0.96 per share, and an increase next year of $1.25 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

The Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):